Lymphocytes in Alzheimer’s Disease Pathology: Altered Signaling Pathways

E-ISSN： 1875-5828|13|4|439-449

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.13, Iss.4, 2016-04, pp. : 439-449

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alzheimer’s disease and NGF signaling

By Salehi A. Delcroix J.-D. Swaab D. F.

Journal of Neural Transmission, Vol. 111, Iss. 3, 2004-03 ,pp. : 323-345

Springer Publishing Company

Access to resources Recommend Favorite

Lewy body pathology in Alzheimer’s disease

By Kotzbauer Paul Trojanowski John Lee Virginia

Journal of Molecular Neuroscience, Vol. 17, Iss. 2, 2001-10 ,pp. : 225-232

Humana Press, Inc

Access to resources Recommend Favorite

Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology

By Obulesu M. Venu R. Somashekhar R.

Neurochemical Research, Vol. 36, Iss. 8, 2011-08 ,pp. : 1329-1335

Springer Publishing Company

Access to resources Recommend Favorite

Associations of Cerebrovascular and Alzheimer’s Disease Pathology with Brain Atrophy

Current Alzheimer Research, Vol. 11, Iss. 4, 2014-05 ,pp. : 309-316

Bentham Science Publishers

Access to resources Recommend Favorite

Novel approaches to models of Alzheimer’s disease pathology for drug screening and development

By Shaughnessy Laura Chamblin Beth McMahon Lori Nair Ayyappan Thomas Mary Wakefield John Koentgen Frank Ramabhadran Ram

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 23-32

Humana Press, Inc

Access to resources Recommend Favorite